Absci

ABSINasdaq United States Health Care Biotechnology: Commercial Physical & Biological Resarch

Market cap

$1.685 B

$9.82 +1.76%

Close of 21 Sept 2026

Revenue

$4.53M

#3305 by revenue

Earnings

-$115.2M

Loss-making

Shares outstanding

171,614,010

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Commercial Physical & Biological Resarch, ranked by market cap

All 12 →

#4Charles River Laboratories InternationalCRL$13.3B
#5IconICLR$13.0B
#6AbsciABSI$1.69B
#7OmniAbOABI$665.9M
#8Nrc HealthNRC$470.5M

What if Absci were worth as much as…

Open the what-if tool →

Gold $30.3T

$176,407.82

Per share 17,964× higher

Bitcoin $1.72T

$10,021.35

Per share 1,021× higher

Nvidia $5.48T

$31,931.30

Per share 3,252× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Absci are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.